02397nam a2200505 i 4500 279583 279583 ocn681839503 OCoLC 20190313121449.0 m o d f cr bn||||||||| 101117s2000 dcua ob f000 0 eng c PUCPR eng rda pn OCLCE OCLCQ OCLCF OCLCO OCLCA OCLCQ CWCLL NJR OCLCQ OCL OCLCA UWO OCLCQ GPO MvI pcc n-us--- 1016-C (online) Y 4.G 74/7:F 31/86 Serial no. 106-60 (United States. Congress. House. Committee on Government Reform) Y 4.G 74/7:F 31/86 United States. Congress. House. Committee on Government Reform, How accurate is the FDA's monitoring of supplements like ephedra? : hearing before the Committee on Government Reform, House of Representatives, One Hundred Sixth Congress, first session, May 27, 1999. How accurate is the Food and Drug Administration's monitoring of supplements like ephedra? Washington : U.S. Government Printing Office, 2000. 1 online resource (iii, 214 pages) : illustrations txt c rdamedia cr rdacarrier "Serial no. 106-60." CRDP Program record. Includes bibliographical references. Description based on online resource; title from PDF title page (govinfo, viewed Feb. 25, 2019). Print version: United States. Congress. House. Committee on Government Reform. How accurate is the FDA's monitoring of supplements like ephedra? (DLC) 00325568 (OCoLC)43523640 https://purl.fdlp.gov/GPO/gpo116620 KF27 .G6 1999h United States. Food and Drug Administration Rules and practice. United States. Food and Drug Administration. fast Dietary supplements Government policy United States. Drugs Side effects Government policy United States. Product safety United States. Ephedra Therapeutic use Side effects United States. Dietary supplements. fast United States. fast Rules. fast Legislative hearings. lcgft sudocs 8 0 0 sudocs 0 Y_4G_747F_3186 0 406591 7 7 55 2019-03-13 0 Y 4.G 74/7:F 31/86 Y 4.G 74/7:F 31/86/O 2019-03-13 00:00:00 1 2019-03-13 8